We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Biosensor Technology Will Offer Immunoassay at POC

By LabMedica International staff writers
Posted on 29 Dec 2008
A unique biosensor technology has the potential to offer lab-quality immunoassay results at point of care (POC).

The new technology, Magnotech, offers the possibility of taking certain complex in vitro diagnostic tests out of the laboratory and into a decentralized setting--including critical care treatment centers, ambulances, general practitioner clinics, and the home. More...
Its biggest impact is likely to be on improved patient outcomes and reduced healthcare costs.

Integrated into a disposable biosensor cartridge that inserts into a hand-held analyzer, Magnotech uses magnetic nanoparticles to measure target molecules in very low, picomolar concentrations in blood or saliva--in a few minutes. The main features of the Magnotech technology are: small sample volumes, ease of use, multianalyte systems, sensitive lab results, and speed.

Philips has demonstrated proof-of-concept for its new biosensor technology in a variety of biologic assays, including sandwich assays for the detection of cardiac Troponin I (cTnI), parathyroid hormone (PTH), and inhibition assays to detect several drugs-of-abuse molecules.

Currently, measuring very low concentrations of biomarkers for the diagnosis of, for example, cardiovascular disease, requires laboratory analysis, large sample volumes, and a time-to-result delay of between 30-60 min.

Royal Philips Electronics (Eindhoven, the Netherlands) unveiled the unique biosensor technology, Magnotech, on November 19-22 at Medica 2008, in Dusseldorf, Germany. Marcel van Kasteel, vice president and CEO of Philips Handheld Immunoassays, explained, "Longterm, we envisage that different testing stations--both conventional, automated labs, and these new, mobile handheld systems--will be part of a diagnostic network, using wired or wireless connectivity and sophisticated healthcare informatics solutions to store and assist in interpreting the data. Clinical decision support systems and data mining would be used to enable fast and accurate decision making."

Magnotech is the brainchild of Prof. Dr. Menno Prins, a research fellow at Philips Research, and professor at the Eindhoven University of Technology (TUE; Eindhoven, the Netherlands) where he is head of the "Molecular Biosensors for Medical Diagnostics” group.

Please see related links below for a video demonstrating the Magnotech technology.

Royal Philips Electronics is a leader in healthcare, lifestyle, and lighting. The company integrates technologies and design into people-centric solutions, based on fundamental customer needs and insights.

Related Links:
Royal Philips Electronics
Eindhoven University of Technology
Video: Magnotech technology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
HPV Test
Allplex HPV28 Detection
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.